ATE267010T1 - Sulfonfluoride zur behandlung von der alzheimerischen krankheit - Google Patents
Sulfonfluoride zur behandlung von der alzheimerischen krankheitInfo
- Publication number
- ATE267010T1 ATE267010T1 AT97938628T AT97938628T ATE267010T1 AT E267010 T1 ATE267010 T1 AT E267010T1 AT 97938628 T AT97938628 T AT 97938628T AT 97938628 T AT97938628 T AT 97938628T AT E267010 T1 ATE267010 T1 AT E267010T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- individual
- disease
- alzheimer
- fluorides
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 title 1
- 150000003457 sulfones Chemical class 0.000 title 1
- KNWQLFOXPQZGPX-UHFFFAOYSA-N methanesulfonyl fluoride Chemical compound CS(F)(=O)=O KNWQLFOXPQZGPX-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000003931 cognitive performance Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08705858 US5798392C1 (en) | 1996-08-28 | 1996-08-28 | Sulfonyl fluorides for the treatment of alzheimer's disease |
| PCT/US1997/015024 WO1998008497A1 (en) | 1996-08-28 | 1997-08-26 | Sulfonyl fluorides for the treatment of alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE267010T1 true ATE267010T1 (de) | 2004-06-15 |
Family
ID=24835244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97938628T ATE267010T1 (de) | 1996-08-28 | 1997-08-26 | Sulfonfluoride zur behandlung von der alzheimerischen krankheit |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5798392C1 (de) |
| EP (1) | EP0921790B1 (de) |
| JP (1) | JP2000517317A (de) |
| AT (1) | ATE267010T1 (de) |
| AU (1) | AU731755B2 (de) |
| CA (1) | CA2264582C (de) |
| DE (1) | DE69729201T2 (de) |
| WO (1) | WO1998008497A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030045005A1 (en) * | 2000-10-17 | 2003-03-06 | Michael Seul | Light-controlled electrokinetic assembly of particles near surfaces |
| CA2437353A1 (en) * | 2001-02-08 | 2002-08-15 | Nps Pharmaceuticals, Inc. | Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
| US8618167B2 (en) * | 2001-11-06 | 2013-12-31 | Board Of Regents, The University Of Texas System | Methods of attenuating cognitive deficits with sulfonyl fluorides |
| US20100256243A1 (en) * | 2009-04-03 | 2010-10-07 | Federica Pericle | Dosing Regimen for the Treatment of Alzheimer's Disease With Sulfonyl Fluorides |
| US8349376B1 (en) * | 2011-03-08 | 2013-01-08 | Bezzek Mark S | Anti-dementia regimen |
| US8846061B1 (en) | 2011-03-08 | 2014-09-30 | Mark S. Bezzek | Multivitamin-mineral regimens for longevity and wellness |
| EP3628315A1 (de) | 2018-09-28 | 2020-04-01 | Université de Caen Normandie | Kombination aus acetylcholinesterase-inhibitor und 5-ht4-rezeptoragonist als neuroprotektives mittel zur behandlung von neurodegenerativen krankheiten |
| AU2022249084A1 (en) * | 2021-04-01 | 2023-11-09 | R.P. Scherer Technologies, Llc | Phospholipids as anion chelating agents in pharmaceutical formulations |
-
1996
- 1996-08-28 US US08705858 patent/US5798392C1/en not_active Expired - Lifetime
-
1997
- 1997-08-26 JP JP10511856A patent/JP2000517317A/ja active Pending
- 1997-08-26 CA CA002264582A patent/CA2264582C/en not_active Expired - Fee Related
- 1997-08-26 EP EP97938628A patent/EP0921790B1/de not_active Expired - Lifetime
- 1997-08-26 AU AU40915/97A patent/AU731755B2/en not_active Ceased
- 1997-08-26 WO PCT/US1997/015024 patent/WO1998008497A1/en not_active Ceased
- 1997-08-26 AT AT97938628T patent/ATE267010T1/de not_active IP Right Cessation
- 1997-08-26 DE DE69729201T patent/DE69729201T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU731755B2 (en) | 2001-04-05 |
| WO1998008497A1 (en) | 1998-03-05 |
| EP0921790B1 (de) | 2004-05-19 |
| CA2264582A1 (en) | 1998-03-05 |
| JP2000517317A (ja) | 2000-12-26 |
| DE69729201T2 (de) | 2005-04-21 |
| DE69729201D1 (de) | 2004-06-24 |
| CA2264582C (en) | 2009-01-06 |
| US5798392C1 (en) | 2002-06-04 |
| EP0921790A1 (de) | 1999-06-16 |
| AU4091597A (en) | 1998-03-19 |
| US5798392A (en) | 1998-08-25 |
| EP0921790A4 (de) | 2000-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94027680A (ru) | Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы | |
| ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
| ATE113846T1 (de) | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. | |
| ATE140388T1 (de) | Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen | |
| AU1049788A (en) | Methods and peptides for the treatment of non-ige-mediated diseases | |
| IL81573A (en) | Pharmaceutical preparations for the treatment of psoriasis containing tamoxifen | |
| DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
| HUP9900511A2 (hu) | Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás | |
| US5798392C1 (en) | Sulfonyl fluorides for the treatment of alzheimer's disease | |
| DE69625682D1 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
| ATE225177T1 (de) | Verwendung von (+)mefloquine zur behandlung von malaria | |
| EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
| PT754054E (pt) | Proteina anti-restenose | |
| ATE126061T1 (de) | Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum. | |
| DE69728536D1 (de) | Zubereitungen enhaltend eine nitroneverbindung für die verwendung bei der behandlung von uveitis | |
| DE69835461D1 (de) | Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren | |
| BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
| DE69739482D1 (de) | Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen | |
| EA200401295A1 (ru) | Статиновая терапия для усиления поддержания когнитивной функции | |
| DE69307702D1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
| NO961180L (no) | Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom | |
| ATE350026T1 (de) | Erhaltung von körpereigenen proteinen | |
| UA9522A (uk) | Спосіб лікування аутоімунного тиреоідиту | |
| MY110416A (en) | Composition for the treatment of schizophrenia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |